|
Markt geschlossen -
London S.E.
17:35:19 17.11.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 13’802.00 GBX | -1.65% |
|
-0.59% | +0.09% |
| 17.11. | Merck stoppt nach Überprüfung der Risiken die Studien zu Blutkrebsmedikament | RE |
| 17.11. | Jefferies belässt Astrazeneca auf 'Buy' - Ziel 17500 Pence | DP |
ETFs investiert in AstraZeneca PLC
| Name | % 1. Jan. | Gewichtung | Volumen | |
|---|---|---|---|---|
| +5.75% | - | 27 154 M€ | ||
| +5.02% | - | 6 576 M€ | ||
| +12.78% | - | 3 469 M€ | ||
| +10.36% | - | 2 627 M€ | ||
| -2.60% | - | 293 M€ | ||
| +9.65% | - | 122 M€ | ||
| +0.47% | - | 51 M€ | ||
| -.--% | - | 22 M€ | ||
| +13.07% | 17.21% | 391 M€ | ||
| +13.20% | 15.79% | 1 024 M€ | ||
| +10.64% | 15.25% | 820 M€ | ||
| +13.66% | 13.81% | 667 M€ | ||
| +10.39% | 9.6% | 1 166 M€ | ||
| +8.39% | 9.6% | 147 M€ | ||
| +7.63% | 9.6% | 106 M€ | ||
| +5.82% | 9.6% | 19 M€ | ||
| +10.82% | 9.5% | 2 462 M€ | ||
| +6.41% | 9.5% | 428 M€ | ||
| +11.38% | 9.32% | 158 M€ | ||
| +10.68% | 9.22% | 265 M€ | ||
| +7.26% | 9.07% | 935 M€ | ||
| +7.50% | 8.9% | 1 190 M€ | ||
| -.--% | 8.9% | 1 190 M€ | ||
| +8.41% | 8.88% | 90 M€ | ||
| +14.43% | 8.88% | 38 M€ | ||
| +9.26% | 8.7% | 679 M€ | ||
| +10.48% | 8.68% | 1 211 M€ | ||
| +8.12% | 8.64% | 44 M€ | ||
| +6.73% | 8.6% | 3 929 M€ | ||
| +7.38% | 8.58% | 6 358 M€ | ||
| +10.86% | 8.57% | 122 M€ | ||
| -.--% | 8.57% | 122 M€ | ||
| +10.60% | 8.56% | 4 353 M€ | ||
| +10.75% | 8.56% | 225 M€ | ||
| +9.51% | 8.53% | 54 M€ | ||
| +6.43% | 8.39% | 56 M€ | ||
| +13.53% | 8.3% | 19 M€ | ||
| +12.94% | 8.11% | 114 M€ | ||
| -.--% | 8.11% | 114 M€ | ||
| +7.96% | 7.88% | 158 M€ | ||
| +12.67% | 7.83% | 97 M€ | ||
| +13.01% | 7.57% | 22 220 M€ | ||
| +10.75% | 7.55% | 544 M€ |
Beschäftigte
96’100
Sektor
Pharmazeutika
Termine
- Börse
- Aktien
- 886455 Aktie
- ETFs AstraZeneca PLC
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
















